For the year ending 2025-12-31, ASTH had $144,944K increase in cash & cash equivalents over the period. $104,491K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 24,076 |
| Depreciation and amortization | 45,749 |
| Amortization of debt issuance cost | 4,050 |
| Share-based compensation | 38,601 |
| Non-cash lease expense | 6,647 |
| Deferred tax | -4,287 |
| Change in fair value of contingent consideration liabilities | 5,166 |
| Other | -2,307 |
| Receivables, net | 9,424 |
| Other receivables | -2,261 |
| Prepaid expenses and other current assets | -4,718 |
| Other assets | -3,505 |
| Accounts payable and accrued expenses | -6,994 |
| Fiduciary accounts payable | -4,699 |
| Medical liabilities | 8,890 |
| Income taxes payable/receivable | 5,326 |
| Operating lease liabilities | -6,049 |
| Other liabilities | -632 |
| Net cash provided by operating activities | 114,597 |
| Payments for business and asset acquisition, net of cash acquired | 548,604 |
| Purchases of investments equity method | 0 |
| Purchase of call option issued in conjunction with equity method investment | 0 |
| Issuance of loans receivable | 1,708 |
| Purchases of property and equipment | 10,106 |
| Proceeds from sale of equity method investment | 15,100 |
| Other | -6,319 |
| Net cash used in investing activities | -538,999 |
| Dividends paid | 7,885 |
| Repayments on debt | 495,289 |
| Borrowings on debt | 1,119,300 |
| Taxes paid from net share settlement of restricted stock | 6,169 |
| Repurchase of treasury shares | 15,429 |
| Deferred financing cost | 19,205 |
| Payment of financing obligation | 0 |
| Payment of contingent consideration liabilities | 8,284 |
| Other | 2,307 |
| Net cash provided by financing activities | 569,346 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | 144,944 |
| Cash, cash equivalents, and restricted cash, beginning of year | 289,101 |
| Cash, cash equivalents, and restricted cash, end of year | 434,045 |
Astrana Health, Inc. (ASTH)
Astrana Health, Inc. (ASTH)